Skip to main content
Home
FULL MENU Close Menu
Home
Home

Steve Stiles

News

Hot weather risk for nonfatal MI hinted for antiplatelets, beta-blockers

Author:
Steve Stiles
Publish date: August 5, 2022

Why taking either drug class would promote nonfatal MIs on high-temperature days, or why it may have appeared that way, isn’t clear, but...

  • Read More

News

Gout flares linked to transient jump in MI, stroke risk

Author:
Steve Stiles
Publish date: August 3, 2022

Causation is plausible, even suspected, say experts, who urge aggressive CV risk-factor management in gout patients and perhaps more willingness...

  • Read More

News

Do ICDs still ‘work’ in primary prevention given today’s recommended HF meds?

Author:
Steve Stiles
Publish date: July 29, 2022

They might offer fewer meaningful survival gains in patients on the four pillars of HFrEF med therapy, researchers speculate from their study.

  • Read More

News

Cardiologists concerned for patient safety after abortion ruling

Author:
Steve Stiles
Publish date: June 28, 2022

Clinicians in many U.S. states are in uncharted territory with the country’s new patchwork of abortion legality, but some specialties may feel the...

  • Read More

News

Pig-heart transplant case published with new details, insights

Author:
Steve Stiles
Publish date: June 27, 2022

For example, heart injury at autopsy didn’t resemble standard graft rejection in humans or other primates, researchers said, nor did viral...

  • Read More

News

Add AFib to noncardiac surgery risk evaluation: New support

Author:
Steve Stiles
Publish date: June 24, 2022

Preexisting atrial fibrillation should again be part of pre–noncardiac surgery cardiac risk assessment, argues a new report.

  • Read More

News

Cause of death in pig heart recipient: New clues

Author:
Steve Stiles
Publish date: June 14, 2022

New details on efforts to identify the mechanism of David Bennett’s death tentatively rule out a few possible suspects that had been at the top of...

  • Read More

News

Paradigm-challenging heart failure treatment strategy hopeful in early trial

Author:
Steve Stiles
Publish date: May 26, 2022

A proposed nerve-ablation technique that questions dogma in heart failure management yielded promising short-term results in a small observational...

  • Read More

News

Voice-analysis app promising as early warning system for heart failure decompensation

Author:
Steve Stiles
Publish date: May 24, 2022

It could potentially help guide heart failure therapy to avert acute decompensations, researchers say. “But of course, we have to show that now in...

  • Read More

News

Porcine virus a suspect in man’s death after pig heart transplant

Author:
Steve Stiles
Publish date: May 5, 2022

That PCMV escaped detection before the operation “could now factor into some people’s questions over whether the experiment should have taken...

  • Read More

News

Cutting dementia risk in AFib: Does rhythm control strategy matter?

Author:
Steve Stiles
Publish date: May 3, 2022

The way sinus rhythm is restored in patients with atrial fibrillation might make a difference to risk for later dementia.

  • Read More

News

Cutting dementia risk in atrial fibrillation: Does rhythm control strategy matter?

Author:
Steve Stiles
Publish date: May 2, 2022

AFib catheter ablation might be more effective than pharmacologic rhythm control alone at cutting dementia risk...

  • Read More

News

DIAMOND: Adding patiromer helps optimize HF meds, foils hyperkalemia

Author:
Steve Stiles
Publish date: April 8, 2022

Hyperkalemia is no reason for suboptimal guideline-directed heart failure medical therapy, given availability of at least one potassium-binding...

  • Read More

News

New HF guidelines feature ‘quad’ therapy, tweaked terminology

Author:
Steve Stiles
Publish date: April 3, 2022

They include new generalist-friendly labels for the traditional but obscurely named four stages of HF that, it is hoped, will have wider reach and...

  • Read More

News

VALOR-HCM: Novel drug may delay, avert invasive therapy in OHCM

Author:
Steve Stiles
Publish date: April 3, 2022

Mavacamten looks promising as a medical alternative to highly invasive septal reduction therapy for patients with obstructive hypertrophic...

  • Read More

Pages

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • last »

Privacy Policy

Terms of Use

Editorial Policy

Cookie Policy

Ad Policy

Medscape Customer Support

Frequently Asked Questions

 

Advertise with MDedge

See more with MDedge! See our Other Publications

MDedge: Keeping You Informed. Saving You Time.

Copyright  © 2022 Frontline Medical Communications Inc., Newark, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

Close